Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jacqueline Seiglie MD, MSc

Jacqueline A. Seiglie MD, MSc

Assistant Professor of Medicine, Harvard Medical School; Endocrinologist, Massachusetts General Hospital, Boston, Massachusetts

Dr. Jacqueline Seiglie is an endocrinologist and diabetologist at Massachusetts General Hospital (MGH) and an Assistant Professor of Medicine at Harvard Medical School. Her research focuses on type 2 diabetes epidemiology in high burden settings, with a regional focus on Latin America, and on the development of scalable interventions to improve diabetes self-care among Latino adults. She earned her medical degree from Harvard Medical School and completed her internal medicine residency and endocrinology, diabetes and metabolism fellowship at MGH.

Recent Contributions to PracticeUpdate:

  1. 54 y/o Male With a History of Diabetes Mellitus, Presumed to be LADA (Positive GAD-65) Presents for a Second Opinion
  2. Diagnosis and Management Changes in Diabetes in Mexico City
  3. Association Between BMI and COVID-19 Hospitalization by Age
  4. Socioeconomic Factors Associated With Hypoglycemia in Patients Starting Second-Line Glucose-Lowering Therapy
  5. Estimates and Projections of Diabetes-Related Health Expenditures
  6. ESC Cardiovascular Disease Statistics 2019
  7. Metabolic Health in the Middle East and North Africa
  8. Rural Areas May Outpace Urban Areas in Rising Levels of Obesity
  9. Community Groups or Mobile Phone Messaging to Prevent and Control Type 2 Diabetes and Intermediate Hyperglycemia
  10. Global Insulin Use Is Estimated to Increase by 20% Between 2018 and 2030

Elsewhere

Most Read This Week

Recently Updated